The Significance of Moving Averages in Xeris Biopharma Holdings Inc Inc. (XERS) Price Performance

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant gain of 52.21% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 60.25%. Over the past 30 days, the price of XERS has fallen by 24.94%. And in the last five days, it has surged by 15.18%.

Xeris Biopharma Holdings Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $6.07 on 03/26/25, while the lowest value for the same period was recorded at $1.72 on 05/09/24.

52-week price history of XERS Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Xeris Biopharma Holdings Inc’s current trading price is -14.99% away from its 52-week high, while its distance from the 52-week low is 200.00%. The stock’s price range during this period has varied between$1.72 and $6.07. The Xeris Biopharma Holdings Inc’s shares, which operate in the Healthcare, saw a trading volume of around 5.21 million for the day, a figure considerably higher than their average daily volume of 3.12 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Xeris Biopharma Holdings Inc (XERS) has experienced a quarterly rise of 42.54% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 794.33M and boasts a workforce of 394 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.06, with a change in price of +1.65. Similarly, Xeris Biopharma Holdings Inc recorded 2,512,199 in trading volume during the last 100 days, posting a change of +47.01%.

XERS Stock Stochastic Average

Xeris Biopharma Holdings Inc’s raw stochastic average for the past 50 days is presently 63.31%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 92.18%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 71.14% and 72.53%, respectively.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.